Your browser doesn't support javascript.
loading
Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
Bridges, Nora C; Taber, Rachel; Foulds, Abigail L; Bear, Todd M; Cloutier, Renee M; McDonough, Brianna L; Gordon, Adam J; Cochran, Gerald T; Donohue, Julie M; Adair, Dale; DiDomenico, Ellen; Pringle, Janice L; Gellad, Walid F; Kelley, David; Cole, Evan S.
Afiliação
  • Bridges NC; Department of Family Medicine, University of Pittsburgh; Schenley Place, Suite 520, 4420 Bayard Street, Pittsburgh, PA 15260, USA. Electronic address: ncb25@pitt.edu.
  • Taber R; Department of Family Medicine, University of Pittsburgh; Schenley Place, Suite 520, 4420 Bayard Street, Pittsburgh, PA 15260, USA.
  • Foulds AL; Division of General Internal Medicine, University of Pittsburgh, 1218 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
  • Bear TM; Department of Family Medicine, University of Pittsburgh; Schenley Place, Suite 520, 4420 Bayard Street, Pittsburgh, PA 15260, USA.
  • Cloutier RM; Program Evaluation and Research Unit (PERU), University of Pittsburgh School of Medicine, 3501 Terrace St., Pittsburgh, PA 15261, USA.
  • McDonough BL; Program Evaluation and Research Unit (PERU), University of Pittsburgh School of Medicine, 3501 Terrace St., Pittsburgh, PA 15261, USA.
  • Gordon AJ; Program for Addiction Research, Clinical Care, Education, and Advocacy, University of Utah School of Medicine, 30 N. 1900 E, Salt Lake City, UT, 84132, USA.
  • Cochran GT; Program for Addiction Research, Clinical Care, Education, and Advocacy, University of Utah School of Medicine, 30 N. 1900 E, Salt Lake City, UT, 84132, USA.
  • Donohue JM; University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, PA, 15261, USA.
  • Adair D; Pennsylvania Office of Mental Health and Substance Abuse Services, Harrisburg, PA 17105, USA.
  • DiDomenico E; Pennsylvania Department of Human Services, 625 Forster St., Harrisburg, PA, 17120, USA.
  • Pringle JL; Program Evaluation and Research Unit (PERU), University of Pittsburgh School of Medicine, 3501 Terrace St., Pittsburgh, PA 15261, USA.
  • Gellad WF; University of Pittsburgh School of Medicine, 3550 Terrace St., Pittsburgh, PA, 15213, USA.
  • Kelley D; Pennsylvania Office of Mental Health and Substance Abuse Services, Harrisburg, PA 17105, USA.
  • Cole ES; University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, PA, 15261, USA.
J Subst Use Addict Treat ; 154: 209133, 2023 11.
Article em En | MEDLINE | ID: mdl-37543217
ABSTRACT

INTRODUCTION:

The opioid epidemic has exacted a significant toll in rural areas, yet adoption of medications for opioid use disorder (MOUD) lags. The Rural Access to Medication Assisted Treatment in Pennsylvania (RAMP) Project facilitated adoption of MOUD in rural primary care clinics. The purpose of this study was to gain a better understanding of the barriers and facilitators operating at multiple levels to access or provide MOUD in rural Pennsylvania.

METHODS:

In total, the study conducted 35 semi-structured interviews with MOUD patients and MOUD providers participating in RAMP. Qualitative analysis incorporated both deductive and inductive approaches. The study team coded interviews and performed thematic analysis. Using a modified social-ecological framework, themes from the qualitative interviews are organized in five nested levels individual, interpersonal, health care setting, community, and public policy.

RESULTS:

Patients and providers agreed on many barriers (e.g., lack of providers, lack of transportation, insufficient rapport and trust in patient-provider relationship, and cost, etc.); however, their interpretation of the barrier, or indicated solution, diverged in meaningful ways. Patients described their experiences in broad terms pointing to the social determinants of health, as they highlighted their lives outside of the therapeutic encounter in the clinic. Providers focused on their professional roles, responsibilities, and operations within the primary care setting.

CONCLUSIONS:

Providers may want to discuss barriers to treatment related to social determinants of health with patients, and pursue partnerships with organizations that seek to address those barriers. The findings from these interviews point to potential opportunities to enhance patient experience, increase access to and optimize processes for MOUD in rural areas, and reduce stigma against people with opioid use disorder (OUD) in the wider community.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidemias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidemias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article